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ABSTRACT
Background and objective Upgrades to electronic
health record (EHR) systems scheduled to be introduced
in the USA in 2014 will advance document
interoperability between care providers. Speciﬁcally, the
second stage of the federal incentive program for EHR
adoption, known as Meaningful Use, requires use of the
Consolidated Clinical Document Architecture (C-CDA) for
document exchange. In an effort to examine and
improve C-CDA based exchange, the SMART
(Substitutable Medical Applications and Reusable
Technology) C-CDA Collaborative brought together a
group of certiﬁed EHR and other health information
technology vendors.
Materials and methods We examined the machine-
readable content of collected samples for semantic
correctness and consistency. This included parsing with
the open-source BlueButton.js tool, testing with a
validator used in EHR certiﬁcation, scoring with an
automated open-source tool, and manual inspection. We
also conducted group and individual review sessions
with participating vendors to understand their
interpretation of C-CDA speciﬁcations and requirements.
Results We contacted 107 health information
technology organizations and collected 91 C-CDA
sample documents from 21 distinct technologies.
Manual and automated document inspection led to 615
observations of errors and data expression variation
across represented technologies. Based upon our analysis
and vendor discussions, we identiﬁed 11 speciﬁc areas
that represent relevant barriers to the interoperability of
C-CDA documents.
Conclusions We identiﬁed errors and permissible
heterogeneity in C-CDA documents that will limit
semantic interoperability. Our ﬁndings also point to
several practical opportunities to improve C-CDA
document quality and exchange in the coming years.
BACKGROUND AND SIGNIFICANCE
Health Level 7 (HL7), a leading standards develop-
ment organization for electronic health informa-
tion, deﬁnes interoperability as ‘the ability of two
parties, either human or machine, to exchange data
or information where this deterministic exchange
preserves shared meaning.’
1 In addition, semantic
interoperability has been operationally deﬁned to
be ‘the ability to import utterances from another
computer without prior negotiation, and have your
decision support, data queries and business rules
continue to work reliably against these utterances.’
2
In our study, we apply the operational deﬁnition
of semantic interoperability to assess structured
data within Consolidated Clinical Document
Architecture (C-CDA) documents, which certiﬁed
electronic health record (EHR) systems must
produce to satisfy federal regulation of EHR adop-
tion. We study core variation in document samples
to examine if reliable semantic interoperability is
possible.
EHR adoption and Meaningful Use
EHR use in the USA has risen rapidly since 2009
with certiﬁed EHRs now used by 78% of ofﬁce-
based physicians and 85% of hospitals.
34
Meaningful Use (MU), a staged federal incentive
program enacted as part of the American Recovery
and Reinvestment Act of 2009, has paid incentives
of US$21 billion to hospitals and physicians for
installing and using certiﬁed EHRs pursuant to spe-
ciﬁc objectives.
56Stage 1 of the program (MU1)
commenced in 2011, Stage 2 (MU2) in 2014, and
Stage 3 is expected by 2017.
While the term interoperability can refer to mes-
sages, documents, and services, MU provides
several objectives that prioritize document inter-
operability.
7 Although multiple document standards
existed prior to MU1, providers with installed
EHRs rarely had the capability to send structured
patient care summaries to external providers or
patients, as noted by the President’s Council of
Advisors on Science and Technology and the
Institute of Medicine.
89MU1 advanced document
interoperability by requiring Continuity of Care
Document (CCD) or Continuity of Care Record
(CCR) implementation as part of EHR certiﬁcation.
Many vendors chose the CCD, which was created
to harmonize the CCR with more widely imple-
mented standards.
10 11 In MU2, the C-CDA, an
HL7 consolidation of the MU1 CCD with other
clinical document types, became the primary stand-
ard for document-based exchange.
12
C-CDA use in document interoperability
The C-CDA is a library of templates using exten-
sible markup language (XML) to transmit patient-
speciﬁc medical data in structured and unstructured
formats.
13 It builds upon the HL7’s Clinical
Document Architecture release 2.0 (CDA) and the
Reference Implementation Model (RIM), a consen-
sus view of how information can be abstractly
represented.
14 The CDA constrains the RIM by
Open Access
Scan to access more
free content
1060 D’Amore JD, et al. J Am Med Inform Assoc 2014;21:1060–1068. doi:10.1136/amiajnl-2014-002883
Research and applicationsapplying principles of how to represent information in clinical
documents. The C-CDA Implementation Guide 1.1 describes
how to create nine CDA document types (table 1), each a com-
bination of speciﬁc sections (eg, problems, allergies) and entries
(eg, diagnosis of heart failure, medication allergy to penicillin).
Moreover, different documents types (eg, a history and physical
vs discharge summary) share common sections to achieve con-
sistency in data representation.
MU2 objectives include the use of C-CDA documents for
both human display and machine-readable data exchange.
71 5
Since C-CDA implementation guidance requires both data struc-
tured in XML and speciﬁc terminologies, healthcare providers
can generate machine-readable documents for individual care
transitions and across a practice to prevent EHR vendor lock-in.
Previous research has cataloged issues associated with past inter-
operability standards, but research speciﬁc to C-CDA is still
limited given the nascent utilization of the standard.
16–19
OBJECTIVES
Those of us (JCM, DAK, KDM, ISK, RBR) involved in the
SMART (Substitutable Medical Applications and Reusable
Technology) Platforms Project, an Ofﬁce of the National
Coordinator for Health Information Technology (ONC)-funded
Special Health Advanced Research Project, have been exploring
ways to integrate medical apps across diverse EHRs.
20 21 To
assess the current state of C-CDA interoperability and prepare
recommendations to improve document quality, the SMART
team engaged Lantana Consulting Group in April 2013 to form
the SMART C-CDA Collaborative.
The Collaborative approached health information technology
vendors for a study of C-CDA quality and variability. Vendors
who participated in the Collaborative provided 2011 Certiﬁed
EHR Technology for a majority of provider attestations for
MU1 from 2011 to 2013.
22 While several vendor applications
received 2014 EHR certiﬁcation before joining the
Collaborative, most received it during the Collaborative’s term,
which ended in December 2013. To identify both application-
speciﬁc and general means to improve the quality of C-CDA
documents, we engaged vendors in discussions and document
reviews to reﬁne our analysis, as well as to hear how and why
vendors made certain implementation decisions. Our interaction
with vendors may have inﬂuenced the quality of C-CDA docu-
ments used during certiﬁcation, but many reported that the




We e-mailed invitations to organizations listed on the Certiﬁed
Health IT Product List (http://oncchpl.force.com/ehrcert).
23 In
cases where SMART or Lantana had prior contact with indivi-
duals within vendor organizations, we sent personal invitations.
We posted public announcements on the SMART Platforms
website and on the HL7’s Structured Document Working Group
mailing list. We provided further details to interested organiza-
tions by phone, informing them of the means for sample collec-
tion and group discussions.
Collection of samples
As a condition of participation, we required vendors to submit
at least one C-CDA document that had been generated by
exporting a ﬁctional patient’s health record from their software
application. To allay concerns, we allowed submitted documents
to be kept private, but nonetheless encouraged vendor partici-
pants to select a sharing policy that included public posting to a
GitHub repository managed by Boston Children’s Hospital
(https://github.com/chb/sample_ccdas).
Automated parsing of samples
C-CDA samples were parsed using the open-source BlueButton.js
tool V .0.0.19, to which one of the authors (JCM) has contribu-
ted.
24 We have previously used BlueButton.js to integrate
C-CDA data into medical applications. Using node.js, we parsed
each C-CDA twice: a ﬁrst pass wrote all data to a text ﬁle, and a
second pass only recorded parsing times to isolate ﬁle writing
time artifacts. All processing was performed on a quad-core
AMD 2.2 GHz workstation with 6 Gb of RAM running
Windows 7 (Microsoft, Redmond, Washington, USA). We
counted each non-null section and JavaScript Object Notation
data elements returned from the parser.
Manual analysis of samples
While only vendor-supplied C-CDA samples were part of the
formal analysis, C-CDA documents from HL7 and other non-
vendor organizations were reviewed for comparison to collected
samples. Two of the authors (JDD, AS) performed the manual




Demographics Allergies Medications Plan of care Problems Procedures Results Social history Vital signs
Other required
sections
Continuity of care document ✓✓ ✓ ✓ ✓ 0
Consultation note ✓ 3
Diagnostic imaging report ✓ 2
Discharge summary ✓✓ ✓ ✓ 2
History and physical note ✓✓ ✓ ✓ ✓ ✓ 8
Operative note ✓✓ 7
Procedure note ✓✓ 4
Progress note ✓ 1
Unstructured document ✓ 0
Only the required domains are shown for each C-CDA document type. Additional information required by MU2 (ie, care team, functional and cognitive status, plan of care goals and
instructions, immunizations, and referral information) are also supported in C-CDA documents. Because C-CDA documents are open templates, vendors may add optional data domains
in order to meet regulatory and business requirements.
C-CDA, Consolidated Clinical Document Architecture; MU, Meaningful Use.
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Research and applicationsinspection, adapting techniques previously used for analysis of
CDA documents.
17
Only a single C-CDA document submission was required to
participate in the SMART C-CDA Collaborative. To give equal
weighting in our analysis to each vendor application, when mul-
tiple samples were submitted from a single application, we
selected the one with as many domains as possible and largest in
kilobytes, together a proxy for the most data. The manual
inspection identiﬁed errors and heterogeneity in the studied
samples, but was conﬁned to seven domains from the ‘Common
Data Set’ deﬁned in MU2: demographics, problems, allergies,
medications, results, vital signs, and smoking status.
15
We deﬁned an error in our study as any XML usage that con-
ﬂicted with mandatory guidance from the HL7 C-CDA 1.1
Implementation Guide.
13 Given this deﬁnition, any document
with an error would not satisfy MU2 requirements for docu-
ment interoperability. While many errors can be identiﬁed by
automated software tools, some require human review (eg,
where the dose of a structured medication entry contradicts
dosing information in the narrative).
Identifying heterogeneity in structured data meant ﬁnding var-
iations in data inclusion, omission, or expression across exam-
ined documents that did not qualify as errors deﬁned above.
Again, while some heterogeneity can be detected by automated
software tools, human reviewers identiﬁed other types of het-
erogeneity which are currently not identiﬁable by software (eg,
the omission of result interpretation as structured information
when known from value and reference range).
Our inspection recorded only the ﬁrst instance of any speciﬁc
error or heterogeneity found in each domain of each sample.
Recording repeated instances of the same issue in an individual
C-CDA would document data frequency and not prevalence of
error types.
We mapped observed errors and heterogeneity to one of six
mutually exclusive categories: (1) incorrect data within XML
elements; (2) terminology misuse or omission; (3) inappropriate
or variable XML organization or identiﬁers; (4) inclusion versus
omission of optional elements; (5) problematic reference to nar-
rative text from structured body; and (6) inconsistent data
representation.
Automated analysis of samples
Automated analysis of the samples made use of the Transport
Testing Tool (TTT) release V .175 (http://transport-testing.nist.gov/
ttt/) from the National Institute of Standard and Technology
(NIST) and the SMART C-CDA Scorecard (http://ccda-scorecard.
smartplatforms.org) from one of the authors (JCM).
TTT returns schema and schematron errors and warnings
describing the conformance of a C-CDA document to the XML
templates and conformance statements published by HL7.
The SMART C-CDA Scorecard performs a set of semantic
checks that ofﬁcial validation tools omit. These checks include
the validation of RxNorm, Systematized Nomenclature of
Medicine (SNOMED), Logical Observation Identiﬁers Name
and Codes (LOINC), and the Uniﬁed Code for Units of Measure
(UCUM) use within a C-CDA document. The Scorecard com-
putes a series of rubrics, each corresponding to a best practice for
C-CDA implementation derived from discussion on an HL7
community mailing list. For example, two rubrics are:
‘Document uses ofﬁcial C-CDA templateIds whenever possible’
and ‘Vitals are expressed with UCUM units.’ The Scorecard
assigns a score from zero to ﬁve for each rubric, allowing partial
credit for documents with incomplete adherence to each rubric.
No score is assigned for a rubric if no relevant data are available.
These scores are combined into section-wide scores by dividing
the number of points earned by the total points possible. A com-
posite score reported as a percentage (0–100%) is produced by
summing the number of points earned across sections and divid-
ing by the total points possible.
Group web conferences
From July through December 2013, SMART and Lantana con-
ducted ten 60-min group meetings to discuss C-CDA implemen-
tation. The protocol consisted of a short review of issues
identiﬁed through analysis of the collected samples and polling
each health information technology vendor to respond to each
issue (eg, ‘When do you include reference ranges as structured
elements vs text strings?’). Written notes, compiled by one of us
(JDD) for each meeting, were published weekly on a participant
message board, which allowed for feedback between meetings
(https://trello.com/b/CicwWfdW/smart-c-cda-collaborative).
One-on-one vendor reviews
From September through December 2013, SMARTand Lantana
scheduled sessions with individual vendors to review their
respective C-CDA samples. Reviews covered speciﬁc observa-
tions about errors and explored variation in C-CDA data repre-
sentations. Each vendor could request a second session and
submit an additional C-CDA sample. Vendor feedback from




Of the 107 individual organizations contacted, 44 (41%)
responded to the invitation. Fourteen organizations submitted
one or more samples from a single application and one organ-
ization provided multiple samples from three separate technolo-
gies. Several respondents did not submit a C-CDA sample.
Supplemental samples came from four organizations who had
openly published their C-CDAs. In total, 91 C-CDA documents
were collected with an average of 4.3 (range 1–20) documents
per vendor application. Samples were categorized (table 2)b y
whether the vendor application had been certiﬁed for MU2 by
study conclusion.
23
Automated parsing of samples
All 91 samples were parsed using BlueButton.js. Parsing results
omitted smoking status because BlueButton.js does not support
the C-CDA section of social history. Since not every C-CDA
Table 2 SMART C-CDA Collaborative tallies: vendors, applications,
and C-CDA samples
MU2 certification status as of
December 2013 Vendors Applications
C-CDA
samples
Certified EHR 12 14 55
Certified modular EHR for C-CDA
exchange (HIE)
33 1 3
Non-certified health IT 4 4 23
Total 19 21 91
Results are categorized by the certification status of a vendor’s application as of
December 2013 but the C-CDA samples submitted by a vendor may have been
different from those submitted for EHR certification.
C-CDA, Consolidated Clinical Document Architecture; EHR, electronic health record;
HIE, health information exchange; IT, information technology; MU, Meaningful Use;
SMART, Substitutable Medical Applications and Reusable Technology.
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tions were parsed per document. For the parsed sections, the
number of non-null data elements totaled 10 220. The extracted
data elements by section were: 1706 for demographics, 620 for
problems, 909 for allergies, 1866 for medications, 3338 for
results, and 1781 for vital signs. The average document size was
135 kb (SD 130 kb) with an average parsing time of 864 ms (SD
862 ms). Approximately 1 s was required to parse 149 kb of
C-CDA data. Document size and average parsing time were
highly correlated (R²=0.971) and the distribution was right-
skewed (ﬁgure 1). Results for the two C-CDA parsing passes
showed an average 2 ms increment for writing data versus only
parsing the documents (R²=0.988); hence parsing is essentially
the entire computing time.
Manual analysis of samples
For the 21 vendor C-CDA samples we analyzed, we observed 615
errors and heterogeneities, assigning 607 (99%) to one of six mutu-
ally exclusive categories (table 3). Eight observations (1%) did not
ﬁt this schema. For each category, the research team selected up to
two examples from examined C-CDA documents that illustrate
one potential type of error or heterogeneity (table 4).
TTT/SMART C-CDA scorecard results
We used both the TTT and SMART C-CDA Scorecard to help
detect and classify errors and types of heterogeneity. TTT
focused on a document’s adherence to a series of structural con-
straints described in the C-CDA 1.1 Implementation Guide,
while the SMART C-CDA Scorecard assessed speciﬁc semantic
issues with data content and terminology.
We applied the TTT to each of the 21 samples that had been
manually inspected and observed:
▸ Ten vendor applications returned no errors.
▸ The remaining 11 had an average of 71 errors (range of 2–
297) with the higher values being observed among non-
certiﬁed vendor applications.
▸ Warnings were issued for all samples, generally for omission
of XML elements, with an average of 78 warnings (range of
7–381) per vendor application.
We submitted the same samples for scoring by the SMART
C-CDA Scorecard, obtaining an average score of 63% (range
23–100%; ﬁgure 2). As expected, no correlation (R
2<0.01) was
observed between TTT results and SMART C-CDA Scorecard
scores because they examine wholly different aspects of C-CDA
document correctness. De-identiﬁed group results were pre-
sented publically and identiﬁed results were shared during indi-
vidual vendor sessions.
Group and one-on-one vendor web conferences
Of the 19 organizations represented by C-CDA samples, 12
attended at least one group call. Six organizations who did not
submit a sample during the outreach also joined the group calls.
On average, eight organizations participated in each group call.
Eleven organizations discussed their samples in one-on-one ses-
sions with the research team, and three requested a second
session. Individual sessions averaged 66 min (range 30–90 min)
for a total of 930 min. Five organizations submitted revised
samples to the Collaborative.
Summation: common trouble spots in C-CDA samples
Based upon our analysis and discussions with Collaborative par-
ticipants, we identiﬁed 11 speciﬁc areas (ie, ‘trouble spots’)i n
examined C-CDA documents. Although not comprehensive,
each trouble spot represents a relevant, common issue in
C-CDA documents. Since not all vendors elected to publicize
their participation in the Collaborative, de-identiﬁed results
were presented in the last group call (ﬁgure 3). The severity and
clinical relevance of these trouble spots vary according to the
context of C-CDA document use. Data heterogeneity or omis-
sion may impose a minimal burden in cases where humans or
computers can normalize or supplement information from other
sources. In other cases, a missing or erroneous code (eg, termin-
ology misuse; table 4) could disrupt vital care activities, such as
automated surveillance for drug–allergy interactions. Because
the severity of trouble spots depends upon speciﬁc clinical
Table 3 Categorized observations (N=615) across 21 C-CDA samples examined
Examined domains from MU common data set
Demographics Allergies Medications Problems Results Smoking status Vital signs Total
Incorrect data within XML elements 10 12 27 24 5 14 5 97
Terminology misuse or omission 9 40 29 12 31 2 19 142
Inappropriate or variable XML organization or identifiers 7 20 13 17 23 10 20 110
Element optionality through inclusion or omission 49 20 40 16 22 1 13 161
Problematic reference to narrative text from structured body 0 6 10 11 3 6 9 45
Inconsistent data representation 23 7 4 4 12 0 2 52
Not elsewhere classified 1 3 2 1 1 0 0 8
Total 99 108 125 85 97 33 68 615
Both errors and heterogeneity observations were recorded in each category with the exception of ‘Inconsistent data representation’ which only included heterogeneity.
C-CDA, Consolidated Clinical Document Architecture; MU, Meaningful Use; XML, extensible markup language.
Figure 1 Parsing times for C-CDA document samples (N=91). C-CDA,
Consolidated Clinical Document Architecture.
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Category C-CDA XML code Type
Incorrect data
doseQuantity is ‘40 mg’ but should be ‘1’ to correspond
to the RxNorm code that specifies tablet dosing
Error
Terminology misuse




Code for a vaccine recorded in the diagnostic results
section whereas it should be in immunizations
Element optionality
Method code is optional and included on only one
sample (eg, patient position as seated for blood
pressure).
Interpretation code is optional for results and often
omitted or left blank. In this example normal can be
inferred from reference range
Inclusion of an XML element
Omission of an XML element
Error
Heterogeneity
Reference to narrative text
Reference to allergic reaction (cough) has no reference to
allergen (aspirin)
Narrative, unstructured body
Structured body only references the reaction
Heterogeneity
Inconsistent representation
Two samples showing a medication to be administered
‘every day’ but units vary from hours to days
Medication timing of “every day”
Separate medication timing of “every day” from different sample
Heterogeneity
C-CDA, Consolidated Clinical Document Architecture; XML, extensible markup language.
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they create to semantic interoperability.
DISCUSSION
We demonstrated that aggregated, structured data covering a
range of clinical information from MU2 C-CDA samples can be
parsed with the open-source BlueButton.js library. This allowed
us to inspect manually and programmatically the structured
content of vendor-supplied documents to answer this question:
will the exchange of C-CDA documents generated by 2014
Certiﬁed EHR Technology be capable of achieving semantic
interoperability? Analyzing these documents, we identiﬁed
many barriers to such interoperability. This leads to recommen-
dations on how to improve C-CDA document quality, and with
such improvements, advance automated document exchange.
Barriers to semantic interoperability
Our observations identify several barriers that will challenge reli-
able import and interpretation of parsed C-CDA documents. It
can be helpful to categorize these issues based on how errone-
ous data can be detected.
Present in automated detection
Some observed violations of the C-CDA speciﬁcation are
already detected by NIST’s TTT validator. For example, the
validator ﬂagged inappropriate null values of ‘UNC,’ which
were likely intended to be ‘UNK’, meaning unknown. Such
errors were unusual among EHR applications since certiﬁcation
requires the production of TTT-validated documents.
Potential for automated detection
Some barriers to semantic interoperability could be detected
with additions to the TTT validator. One observed area was
internal C-CDA consistency, which could be evaluated using
logical correlations of structured entries. For example, if a
C-CDA problem has an observation status asserting that the
problem is biologically active, it would be incorrect for the
concern status code to be ‘completed’ or for the patient’s timing
information to include a problem resolution date.
Terminology issues were prevalent and also amendable to
automated detection. In several samples we observed the use of
non-existent, deprecated, or misleading codes, and non-
adherence to required value sets. For example, one sample used
the deprecated LOINC code ‘41909-3’ which has been super-
seded by LOINC code ‘39156-5’ to represent body mass index.
There were also more complex concerns. For example, medica-
tion allergies should be encoded at the ingredient level (eg,
‘aspirin’) or drug class level (eg, ‘sulfonamides’), but some
samples reported allergens at the semantic clinical drug level
(eg, ‘aspirin 81 mg oral tablet’). While the latter representation
is syntactically correct, it is clinically questionable to say that
someone is allergic to a speciﬁc form and dose of aspirin. To
reconcile such terminology issues, receivers of C-CDA docu-
ments would need to perform substantial manual reconciliation
or apply intricate normalizing logic to the hierarchy of potential
RxNorm codes.
Issues difﬁcult to detect automatically
Heterogeneity in data representation imposes interoperability
barriers that are difﬁcult to detect automatically without clear
guidance. We frequently observed variations where the C-CDA
speciﬁcation does not provide uniform guidance. Telephone
Figure 2 SMART C-CDA Scorecard histogram for C-CDA samples
(N=21). C-CDA, Consolidated Clinical Document Architecture; SMART,
Substitutable Medical Applications and Reusable Technology.
Figure 3 Chief trouble spots in C-CDA documents (N=21). C-CDA, Consolidated Clinical Document Architecture.
D’Amore JD, et al. J Am Med Inform Assoc 2014;21:1060–1068. doi:10.1136/amiajnl-2014-002883 1065
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multiple ways to encode and no testable conformance is pro-
vided.
13 In collected samples, we found 12 distinct patterns for
recording a telephone number through combination of dashes,
parentheses, periods, and leading characters. These representa-
tions are straightforward for humans to interpret but automated
tools require speciﬁcity on permissible representations. Many
variations in data representation may be addressed through
lightweight data consumption normalization algorithms (eg,
regular expressions for a telephone number).
Data optionality introduces two large challenges for semantic
interoperability. First, the data are not present for certain down-
stream clinical workﬂows and applications. For example, the
absence of medication administration timing (eg, ‘take every
8 hours’) prevents generation of automated reminders to
promote medication adherence. Second, the absence of data
may only reﬂect that the certiﬁed technology never populates
and does not convey whether the data were known, unknown,
or not structured in a vendor’s application. Such heterogeneity
creates instances where the receiver cannot disambiguate data
context.
Many of these observations may have a straightforward
explanation. Several vendors explained that they focused devel-
opment efforts on C-CDA generation to pass TTT validation
and less on provider demands for semantic interoperability.
Almost all vendors commented that they had too few implemen-
tation examples to guide them in expressing common clinical
data and ambiguous guidance from regulatory and standards
development organizations.
Improving C-CDA document quality
We identify four areas—spanning standards development, imple-
mentation, and policy—that can lead to improved C-CDA docu-
ment quality. Each of the recommendations we make in these
areas can be weighed for its potential beneﬁt against burden for
implementation.
Provide richer samples in publically accessible format
Vendors commented in the Collaborative that they did not
always know how to represent data within the C-CDA. While
the ONC created a website to assist in C-CDA implementation
and testing (http://www.sitenv.org/) and HL7 increased its help
desk content, vendors suggested these were inadequate and
sometimes unclear. There is need for a site where public
samples and common clinical scenarios of C-CDA documents,
sections, and entries can be queried. We posted samples to the
Boston Children’s Hospital’s public C-CDA repository, when
permitted by vendors. HL7 also supports this goal through the
commission of a CDA Example Task Force (http://wiki.hl7.org/
index.php?title=CDA_Example_Task_Force). A simple and
powerful solution would be to require every technology to
publish C-CDA documents with standardized ﬁctional data used
in EHR certiﬁcation. While vendors may take different imple-
mentation approaches, publication would foster transparent dis-
cussion between vendors, standards bodies, and providers.
Validate codes
Many errors cataloged by this research would not exist if certiﬁ-
cation tools used by testing bodies included terminology vetting
to validate codes and value set membership. Because the
C-CDA includes dozens of reference vocabularies in its imple-
mentation, testing for appropriate conformance to common
vocabularies, such as SNOMED, LOINC, RxNorm, and
UCUM, should be part of certiﬁcation. Although many of the
large value sets referenced by C-CDA are dynamic and are
subject to change, this is reasonably addressable if reference ter-
minology systems were maintained and hosted by an authority,
such as the National Library of Medicine. Because there is no
such authority today, the SMART C-CDA Scorecard hosted
unofﬁcial vocabulary sources for its C-CDA scoring.
Reduce data optionality
MU2 regulations have taken steps to reduce optionality by
requiring a Common Data Set. The Common Data Set,
however, does not constrain C-CDA optionality at a granular
level. In effect, this permits vendors to omit data. For example,
vendors must include an appropriate RxNorm code for each
medication in C-CDA documents but otherwise may populate
its dose, timing, and route of administration with null values.
Moreover, MU2 data requirements imperfectly correspond to
HL7 C-CDA speciﬁcations. For example, no single document
type in the C-CDA library requires all components of the
Common Data Set, so optional sections must be used to meet
MU2 requirements. We therefore recommend that regulations
require EHR vendors to populate known data in C-CDA
documents.
Monitor and track real-world document quality
In real-world clinical environments, a multitude of C-CDA
documents will be generated to satisfy clinical workﬂows. To
quantify and improve document quality, metrics could be calcu-
lated using a C-CDA quality surveillance service running within
the ﬁrewall or at a trusted cloud provider. Such a service could
use existing tools, such as the TTT validator and SMART
C-CDA Scorecard. These services could also be offered through
health information exchanges that transmit C-CDA documents
between organizations.
Advancing C-CDA document exchange
MU2 requires providers to exchange C-CDA documents for
10% of care transitions and for certiﬁed EHR technology to be
capable of ingesting select data upon receipt. This is a signiﬁcant
advance from MU1, where only data display and testing of
exchange were required.
62 5According to MU2 regulations,
however, the intake of clinical data for certiﬁed systems need
not be fully automated.
7 This is entirely appropriate given the
issues identiﬁed in this research.
To advance automated document exchange, we suggest
vendors and policy makers consider Postel’s Law. This law, also
known in computing as the robustness principle, states ‘be con-
servative in what you send, be liberal in what you accept from
others.’
26 Our recommendations to provide more robust exam-
ples, validate codes, and reduce data optionality will reduce
variability in the export of C-CDA documents, addressing the
ﬁrst half of this principle.
To improve the liberal consumption of C-CDA documents,
intelligent parsing could normalize some aspects of heterogen-
eity. Such software could detect common variations in units, ter-
minology, and data expression to return a more consistent data
set from C-CDA documents. Our recommendation to monitor
actual C-CDA document exchange would serve vendors well as
they write normalizing algorithms. However, even the best
engineering cannot reliably populate missing data or resolve
conﬂicting statements, so there will be an upper bound as to
what can be normalized. While Postel’s Law cannot be directly
enforced through regulation, a combination of policy changes
with community support of our recommendations would move
real-world C-CDA exchange closer to realizing this principle.
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Research and applicationsA further challenge for real-world document exchange also
emerged in this study. Latency of C-CDA document production
and consumption, while not a barrier to semantic interoperabil-
ity, may limit application responsiveness. Automated parsing
using BlueButton.js, which provides minimal C-CDA normaliz-
ing logic, requires up to several seconds for larger documents.
Intelligent normalization, network latency, and C-CDA gener-
ation time, none of which we measured in our research, would
add to such computational time. Together these considerations
suggest a limited role for C-CDA usage in low latency services,
such as concurrent clinical decision support or other third party
applications.
Caveats
When providers adopt certiﬁed software for MU2, we expect
C-CDA exports will exhibit many of the challenges we observed
in our samples. Nonetheless, our ﬁndings about the readiness of
C-CDA documents for interoperability have several limitations.
First, our samples represented technologies that voluntarily sub-
mitted or publicized their C-CDA documents. While participat-
ing vendors represent a majority of the certiﬁed EHR market,
we examined only ﬁctional patient records from vendor test or
development environments. These ﬁctional records represented
varying clinical scenarios individually created by vendors. Using
a standard data set based on consistent clinical conditions from
all technologies would have yielded greater comparative ana-
lysis. Second, our ﬁndings do not capture real-world implemen-
tation by hospitals and physicians, since MU2 had not yet been
implemented during the research. We anticipate additional
issues will surface in the thousands of upcoming C-CDA deploy-
ments. Third, we focused exclusively on seven clinical domains
from the Common Data Set. Had we scrutinized other C-CDA
domains, we would likely have recorded additional errors and
heterogeneity. Finally, while we examined C-CDA documents
and discussed their production rationale with vendors as exter-
nal observers, we were unable to examine any vendor’s C-CDA
consumption and reconciliation algorithms. This would have
provided further insight into the challenges of semantic inter-
operability but was beyond the scope of our research.
These limitations in aggregate have likely caused us to under-
state the frequency and types of observed errors and heterogen-
eity that will be observed in real C-CDA exchange. Our
ﬁndings, however, materially capture the problems facing
C-CDA document exchange for MU2.
CONCLUSION
Although progress has been made since Stage 1 of MU, any
expectation that C-CDA documents could provide complete and
consistently structured patient data is premature. Based on the
scope of errors and heterogeneity observed, C-CDA documents
produced from technologies in Stage 2 of MU will omit key
clinical information and often require manual data reconcili-
ation during exchange.
In an industry often faulted for locking down data and stiﬂing
interoperability, we were heartened by Collaborative participants
who helped identify speciﬁc problems and equally speciﬁcw a y st o
improve document exchange. This research demonstrated the
power of group collaboration and utility of open-source tools to
parse documents and identify latent challenges to interoperability.
Future policy, market adoption, and availability of widespread
terminology validation will determine if C-CDA documents can
mature into efﬁcient workhorses of interoperability. Our ﬁnd-
ings suggest that knowledge and example repositories, increas-
ing rigor in document production and validation, and data
quality services that work for certiﬁcation and post-certiﬁcation
validation will all be needed to advance C-CDA based technolo-
gies. However, without timely policy to move these elements
forward, semantically robust document exchange will not
happen anytime soon.
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